Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Evaluation of potential therapies in maintaining remission in Crohn's disease

Sep. 13, 1996

Trypsin inhibitors for pancreatitis

Sep. 6, 1996

LeukoSite awarded SBIR grant for inflammatory bowel disease research

Sep. 6, 1996

Yamanouchi reveals 5HT3 agonist

Aug. 30, 1996

Provir effective in patients with travelers' diarrhea

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

Hepatitic C infection drug discovery alliance formed

Aug. 23, 1996

Tritec approved for U.S. market

Aug. 23, 1996

HemoCleanse, VivoRx to collaborate on bioartificial liver device

Aug. 16, 1996

Hepagene efficacy confirmed in phase III

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...